Camber Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-852,900
| Closed | -$33.1M | – | 37 |
|
|
2024
Q1 | $33.1M | Sell |
852,900
-197,100
| -19% | -$7.65M | 0.81% | 20 |
|
|
2023
Q4 | $32.3M | Hold |
1,050,000
| – | – | 0.82% | 21 |
|
|
2023
Q3 | $23.5M | Hold |
1,050,000
| – | – | 0.77% | 29 |
|
|
2023
Q2 | $22.6M | Hold |
1,050,000
| – | – | 0.73% | 28 |
|
|
2023
Q1 | $25.2M | Hold |
1,050,000
| – | – | 0.77% | 24 |
|
|
2022
Q4 | $24.4M | Hold |
1,050,000
| – | – | 0.84% | 24 |
|
|
2022
Q3 | $16.8M | Hold |
1,050,000
| – | – | 0.52% | 37 |
|
|
2022
Q2 | $18.6M | Hold |
1,050,000
| – | – | 0.81% | 28 |
|
|
2022
Q1 | $21.4M | Hold |
1,050,000
| – | – | 0.77% | 30 |
|
|
2021
Q4 | $19.6M | Sell |
1,050,000
-950,000
| -48% | -$17.7M | 0.67% | 27 |
|
|
2021
Q3 | $39.5M | Hold |
2,000,000
| – | – | 1.22% | 25 |
|
|
2021
Q2 | $47.3M | Hold |
2,000,000
| – | – | 1.59% | 23 |
|
|
2021
Q1 | $47.4M | Hold |
2,000,000
| – | – | 1.63% | 19 |
|
|
2020
Q4 | $40.1M | Hold |
2,000,000
| – | – | 1.41% | 20 |
|
|
2020
Q3 | $41.6M | Hold |
2,000,000
| – | – | 2.2% | 15 |
|
|
2020
Q2 | $35M | Hold |
2,000,000
| – | – | 2% | 16 |
|
|
2020
Q1 | $32.7M | Buy |
+2,000,000
| New | +$32.7M | 1.95% | 19 |
|